Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 16

    1.

    Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects.

    Di Marzo V, Verrijken A, Hakkarainen A, Petrosino S, Mertens I, Lundbom N, Piscitelli F, Westerbacka J, Soro-Paavonen A, Matias I, Van Gaal L, Taskinen MR.

    Eur J Endocrinol. 2009 Nov;161(5):715-22. Epub 2009 Sep 10.PMID: 19745037 [PubMed - indexed for MEDLINE]Related articles

    2.

    Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes.

    Soro-Paavonen A, Watson AM, Li J, Paavonen K, Koitka A, Calkin AC, Barit D, Coughlan MT, Drew BG, Lancaster GI, Thomas M, Forbes JM, Nawroth PP, Bierhaus A, Cooper ME, Jandeleit-Dahm KA.

    Diabetes. 2008 Sep;57(9):2461-9. Epub 2008 May 28.PMID: 18511846 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The AGE/RAGE axis in diabetes-accelerated atherosclerosis.

    Jandeleit-Dahm K, Watson A, Soro-Paavonen A.

    Clin Exp Pharmacol Physiol. 2008 Mar;35(3):329-34. Review.PMID: 18290873 [PubMed - indexed for MEDLINE]Related articles

    4.

    Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance.

    Adiels M, Westerbacka J, Soro-Paavonen A, Häkkinen AM, Vehkavaara S, Caslake MJ, Packard C, Olofsson SO, Yki-Järvinen H, Taskinen MR, Borén J.

    Diabetologia. 2007 Nov;50(11):2356-65. Epub 2007 Sep 12.PMID: 17849096 [PubMed - indexed for MEDLINE]Related articles

    5.

    Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDL.

    Soro-Paavonen A, Naukkarinen J, Lee-Rueckert M, Watanabe H, Rantala E, Soderlund S, Hiukka A, Kovanen PT, Jauhiainen M, Peltonen L, Taskinen MR.

    J Lipid Res. 2007 Jun;48(6):1409-16. Epub 2007 Mar 19.PMID: 17372331 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    ApoE polymorphism is associated with C-reactive protein in low-HDL family members and in normolipidemic subjects.

    Kahri J, Soro-Paavonen A, Ehnholm C, Taskinen MR.

    Mediators Inflamm. 2006;2006(3):12587.PMID: 16951484 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Novel therapeutics for diabetic micro- and macrovascular complications.

    Soro-Paavonen A, Forbes JM.

    Curr Med Chem. 2006;13(15):1777-88. Review.PMID: 16787220 [PubMed - indexed for MEDLINE]Related articles

    8.

    Metabolic syndrome aggravates the increased endothelial activation and low-grade inflammation in subjects with familial low HDL.

    Soro-Paavonen A, Westerbacka J, Ehnholm C, Taskinen MR.

    Ann Med. 2006;38(3):229-38.PMID: 16720437 [PubMed - indexed for MEDLINE]Related articles

    9.

    Decreased high-density lipoprotein (HDL) particle size, prebeta-, and large HDL subspecies concentration in Finnish low-HDL families: relationship with intima-media thickness.

    Watanabe H, Söderlund S, Soro-Paavonen A, Hiukka A, Leinonen E, Alagona C, Salonen R, Tuomainen TP, Ehnholm C, Jauhiainen M, Taskinen MR.

    Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):897-902. Epub 2006 Feb 9.PMID: 16469947 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Overproduction of large VLDL particles is driven by increased liver fat content in man.

    Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, Vehkavaara S, Häkkinen A, Olofsson SO, Yki-Järvinen H, Borén J.

    Diabetologia. 2006 Apr;49(4):755-65. Epub 2006 Feb 4.PMID: 16463046 [PubMed - indexed for MEDLINE]Related articles

    11.

    Cross-species analyses implicate Lipin 1 involvement in human glucose metabolism.

    Suviolahti E, Reue K, Cantor RM, Phan J, Gentile M, Naukkarinen J, Soro-Paavonen A, Oksanen L, Kaprio J, Rissanen A, Salomaa V, Kontula K, Taskinen MR, Pajukanta P, Peltonen L.

    Hum Mol Genet. 2006 Feb 1;15(3):377-86. Epub 2005 Dec 15.PMID: 16357106 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    USF1 and dyslipidemias: converging evidence for a functional intronic variant.

    Naukkarinen J, Gentile M, Soro-Paavonen A, Saarela J, Koistinen HA, Pajukanta P, Taskinen MR, Peltonen L.

    Hum Mol Genet. 2005 Sep 1;14(17):2595-605. Epub 2005 Aug 2.PMID: 16076849 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Hypertriglyceridemia is associated with prebeta-HDL concentrations in subjects with familial low HDL.

    Söderlund S, Soro-Paavonen A, Ehnholm C, Jauhiainen M, Taskinen MR.

    J Lipid Res. 2005 Aug;46(8):1643-51. Epub 2005 May 16.PMID: 15897606 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    A male-specific quantitative trait locus on 1p21 controlling human stature.

    Sammalisto S, Hiekkalinna T, Suviolahti E, Sood K, Metzidis A, Pajukanta P, Lilja HE, Soro-Paavonen A, Taskinen MR, Tuomi T, Almgren P, Orho-Melander M, Groop L, Peltonen L, Perola M.

    J Med Genet. 2005 Dec;42(12):932-9. Epub 2005 Apr 12.PMID: 15827092 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Locus for quantitative HDL-cholesterol on chromosome 10q in Finnish families with dyslipidemia.

    Lilja HE, Suviolahti E, Soro-Paavonen A, Hiekkalinna T, Day A, Lange K, Sobel E, Taskinen MR, Peltonen L, Perola M, Pajukanta P.

    J Lipid Res. 2004 Oct;45(10):1876-84. Epub 2004 Jul 16.PMID: 15258200 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).

    Pajukanta P, Lilja HE, Sinsheimer JS, Cantor RM, Lusis AJ, Gentile M, Duan XJ, Soro-Paavonen A, Naukkarinen J, Saarela J, Laakso M, Ehnholm C, Taskinen MR, Peltonen L.

    Nat Genet. 2004 Apr;36(4):371-6. Epub 2004 Feb 29.PMID: 14991056 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...